Alzai Health Corp.
ALZI · V · Healthcare / Biotechnology
0.16CAD+0.01 (+6.67%)
Price History
Full chartMarket Stats
Previous Close0.15
Open0.16
Day Range0.16 – 0.16
52-Week Range0.275 – 0.50
Volume5.00K
Market Cap19.44M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.06
Dividend Yield0.00%
50-Day Avg0.3625
200-Day Avg0.3962
About
Alzai Health Corp., a healthcare technology company, provides artificial intelligence driven solution for risk screening. The company offers risk screening solutions for Mild Alzheimer's Disease and Mild Cognitive Impairment. It caters to various markets including healthcare providers and payors, pharmaceutical companies, research organizations, and research sites, clinical trials and research companies, and public health and private payors. The company was incorporated in 2024 and is based in Toronto, Canada.
Company Details
- SectorHealthcare
- IndustryBiotechnology
- CEOMr. Hayim Raclaw
- Employees5
- Headquarters22 Adelaide Street West, Toronto, ON, Canada, M5H 4E3, Canada
- Websitehttps://alzaihealth.com
Leadership
- Mr. Hayim RaclawCo-Founder, Chairman & CEO · b. 1976
- Mr. Roy KaitCo-Founder, Chief Revenue Officer & Director · b. 1977
- Dr. Amir Glik M.D.Co-Founder, Chief Medical Officer & Director · b. 1977
- Dr. Chen HajajCo-Founder & Head of Data Science
- Dr. Anat GoldsteinCo-Founder & AI Expert
- Mr. Ofri KaitCo-Founder, Director of Business Development & Operations
- Mr. Israel MesserCFO & Corporate Secretary · b. 1975
- Jenny GreerDirector of Administration
Financials
Income Statement
Balance Sheet
Cash Flow
Key Statistics & Ratios
Market Cap19.44M
Enterprise Value24.54M
Trailing P/E0.00
Forward P/E0.00
Price / Sales281.36
Price / Book0.00
EPS-0.06
Book Value-0.025
Revenue (TTM)69.09K
Gross Profit (TTM)-480.37K
EBITDA-3.99M
Profit Margin0.00%
Operating Margin-2217.17%
Return on Equity0.00%
Return on Assets-469.01%
Shares Outstanding64.80M
Shares Float51.54M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%